Pronutria Gains $12.5 Million Funding For Protein Product Trials
This article was originally published in The Tan Sheet
Executive Summary
The start-up developer of medical foods and supplements is conducting clinical trials on two candidates to stave off muscle loss in elderly people. The firm soon may begin development of therapeutic product candidates with a separate business unit.
You may also be interested in...
Will The Rising Tide Of Rx Omega-3s Float The Fish Oil Supplement Market?
Omega-3 fish oils, once exclusive to the realm of dietary supplements, increasingly are swimming upstream into prescription drugs – a trend with both positive and negative implications for supplements.
AAVLife: Another Gene Therapy Effort To Treat Friedreich's Ataxia
With the launch of AAVLife, Versant Ventures adds to its gene therapy portfolio, and people with Friedreich's ataxia can look to another program that takes aim at the rare inherited disease.
With AAVLife Debut, Another Gene Therapy Effort To Treat Friedreich's Ataxia
With the launch of AAVLife, Versant Ventures adds to its gene therapy portfolio, and people with Friedreich's ataxia can look to another program that takes aim at the rare inherited disease.